Telehealth & Digital Health

A press release announced a bright new chapter for DBH. The real story? A $280M debt default, a lender takeover, and a new CEO's daunting mission.

A pivotal partnership between WeInfuse and Trial IQ leverages AI to bring clinical trials to local infusion centers, signaling a major shift in drug development.

As its CEO heads to a top investor conference, Zealand Pharma leverages AI and novel peptides to challenge giants in the multi-billion-dollar obesity market.

A new study reveals an 'early warning system' in infant guts, offering a window to combat the atopic march before allergies take hold. Is this the future?

Mindray's new Hepatus-Series goes beyond a simple product launch, integrating AI-driven elastography to transform GI diagnostics and challenging market norms.

By turning 2,792 miles of GPS data into a stop-motion film, a nonprofit is redefining advocacy and inviting the world to run for a cause.

Nephrodite's implantable dialysis system just entered a key FDA program, signaling a major shift in treating kidney failure. Is freedom from the dialysis chair finally in sight?

FDA clearance for Pulmera's CBeam platform could democratize surgery by turning standard 2D X-ray machines into advanced 3D imagers, slashing costs.

Health Union's latest awards aren't just for recognition. They're building a new strategic infrastructure for patient influence, complete with certifications.

As one major allergy drug exits, a biotech startup is testing a new path: a microneedle skin stamp. Is this the future of allergy treatment?

A strategic investment in AxisCare signals a major shift as private equity fuels AI's move from the data center to the living room, reshaping elder care.

Medscape's new AI symposium aims to guide hematologists through an ethical revolution, promising to enhance, not replace, clinical expertise. Is this the future?

With an $18M Series A, Novellia is flipping the script on real-world data, empowering patients to solve a decades-old, multi-billion-dollar R&D bottleneck.

Co-Diagnostics is developing a point-of-care Ebola test promising 30-minute results. But can it navigate regulatory hurdles and reach the front lines in time?

The Dallas Cowboys are using a new device to build muscle. It’s part of a high-stakes trend where technology is redefining athlete recovery and longevity.

A new study on couples' supplements shows impressive well-being gains, but a closer look at the methodology reveals a gap between marketing and hard science.

A new partnership is democratizing science for wellness brands, making it faster and cheaper to prove their final products work and earn customer trust.

A new AI platform promises to personalize licensure prep for healthcare professionals. Can its adaptive learning and rapid scaling disrupt a crowded industry?

Shanti Recovery & Wellness gains DHCS accreditation, launching a virtual IOP that combines clinical therapy with holistic practices for California adults.

A $1.6M mobile dental clinic in Ottawa is more than a local grant; it's a key test of Canada's new, two-pronged strategy to operationalize health equity.